Table 1

Baseline characteristics according to follow-up

Consent to post-ACCORD follow-up
Baseline characteristicNo (n = 1,650)Yes (n = 8,601)P value
Females, n (%)630 (38.2)3,322 (38.6)0.74
Age (years)63.7 (7.7)62.0 (6.6)0.03
Duration of diabetes (years)11.2 (8.3)10.8 (7.7)0.14
BMI (kg/m2)32.2 (5.5)32.3 (5.5)0.68
Waist circumference (cm)107.3 (14.2)106.7 (13.8)0.09
Blood pressure (mmHg)
 Systolic138 (18)136(17)<0.001
 Diastolic75 (11)75 (11)0.40
Prior cardiovascular disease, n (%)748 (45.3)2,861 (33.3)<0.001
Current smoker, n (%)292 (17.7)1,137 (13.2)<0.001
Postsecondary education, n (%)844 (57.2)5,175 (60.2)<0.001
Ethnicity, n (%)
 White955 (57.9)5,438 (63.2)
 Black414 (25.1)1,539 (17.9)
 Hispanic136 (8.2)601 (7.0)
 Other145 (8.8)1,023 (11.9)<0.001
Key medications, n (%)
 Insulin628 (38.1)2,953 (34.3)0.004
 Metformin884 (53.6)5,251 (61.1)<0.001
 Sulfonylurea771 (46.7)4,365 (50.7)0.003
 Thiazolidinedione285 (17.3)1,697 (19.7)0.02
 Statin937 (56.8)5,427 (63.1)<0.001
 ACE inhibitor or ARB1,102 (61.9)5,840 (67.9)0.38
 Acetylsalicylic acid836 (50.7)4,743 (55.1)<0.001
Laboratory values
 HbA1c (%)8.4 (1.2)8.3 (1.0)<0.001
 Serum creatinine (mg/dL)0.95 (0.26)0.90 (0.22)<0.001
 eGFR (mL/min)90.6 (33.4)91.1 (25.8)0.54
 Urine albumin-to-creatinine ratio18.3 (8.0, 72.0)12.9 (6.7, 39.8)<0.001
 Cholesterol (mg/dL)186.1 (43.7)182.8 (41.5)0.005
  LDL 108.1 (35.7)104.3 (33.5)<0.001
  HDL41.8 (12.4)41.9 (11.5)0.68
 Triglycerides (mg/dL)154 (102, 226)155 (107, 229)0.76
  • Data are n (%), mean (SD), or median (interquartile range).

  • ARB, angiotensin receptor blocker; eGFR, estimated glomerular filtration rate.